Calidi Biotherapeutics, Inc. (CLDI)
(Delayed Data from AMEX)
$7.10 USD
+6.51 (1,097.10%)
Updated Aug 5, 2025 03:55 PM ET
After-Market: $7.03 -0.07 (-0.99%) 4:54 PM ET
4-Sell of 5 4
F Value F Growth F Momentum F VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
CLDI 7.10 +6.51(1,097.10%)
Will CLDI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CLDI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CLDI
Calidi Biotherapeutics, Inc. (CLDI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
CLDI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for CLDI
CLDI Trading Halted Due to Volatility Pause
Calidi Biotherapeutics (CLDI) Resumes Trading: Key Insights for Investors
Calidi Biotherapeutics Inc trading resumes
Calidi Biotherapeutics Inc trading halted, volatility trading pause
12 Health Care Stocks Moving In Tuesday's Intraday Session